Klaus Armin Nave

1999- Neurogenetics Max-Planck-Institute for Experimental Medicine, Göttingen, Germany 
Neurogenetics, neuron-glia interactions
"Klaus Nave"
Mean distance: 13.2 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Goebbels S, Nave KA. (2019) Conditional Mutagenesis in Oligodendrocyte Lineage Cells. Methods in Molecular Biology (Clifton, N.J.). 1936: 249-274
Nave KA, Ehrenreich H. (2019) Time to revisit oligodendrocytes in multiple sclerosis. Nature Medicine
Erwig MS, Patzig J, Steyer AM, et al. (2019) Anillin facilitates septin assembly to prevent pathological outfoldings of central nervous system myelin. Elife. 8
Prukop T, Stenzel J, Wernick S, et al. (2019) Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). Plos One. 14: e0209752
Lüders KA, Nessler S, Kusch K, et al. (2019) Maintenance of high proteolipid protein level in adult central nervous system myelin is required to preserve the integrity of myelin and axons. Glia
Scapin C, Ferri C, Pettinato E, et al. (2018) Enhanced axonal Neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model. Human Molecular Genetics
Deakin IH, Godlewska BR, Walker MA, et al. (2018) Altered hippocampal gene expression and structure in transgenic mice overexpressing neuregulin 1 (Nrg1) type I. Translational Psychiatry. 8: 229
Schirmer L, Möbius W, Zhao C, et al. (2018) Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity. Elife. 7
Fledrich R, Abdelaal T, Rasch L, et al. (2018) Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications. 9: 3025
Stassart RM, Möbius W, Nave KA, et al. (2018) The Axon-Myelin Unit in Development and Degenerative Disease. Frontiers in Neuroscience. 12: 467
See more...